Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Hervé Perron

Hervé Perron

Chief Scientific Officer and Director,
GeNeuro SA
Switzerland
GeNeuro
Switzerland

Biography

Hervé, JF, Perron has completed his PhD in 1991 (Virology) and HDR (Professor Thesis; Biology) in 2000 from the Faculty of Medicine, Joseph Fourier University, Grenoble-France. He isolated and characterized a novel retroviral element from Multiple Sclerosis (MSRV), itself defining a novel family of human endogenous elements (HERV-W). He reviewed about a hundred manuscripts for more than 40 scientific and medical journals and is author in about 70 peer-reviewed publications. He is presently Chief Scientific Officer of Geneuro SA, Geneva-Switzerland. Geneuro develops innovative humanized antibody treatments for Multiple Sclerosis and for other diseases involving HERV-W as psychoses associating neuroinflammation.

Research Interest

Hervé Perron was Research Director of R&D within bioMérieux for the development of in vitro diagnostics in the domain of Neurological diseases. He was Scientific Director of bioMérieux STELHYS, a spin-off dedicated to the evaluation of developments of upstream research projects. Hervé is a co-founder and Chief Scientific Officer of GeNeuro and the general manager of GeNeuro-Innovation.